Prostate Cancer Trials


The ENZAMET trial is for men with metastatic prostate cancer commencing androgen deprivation therapy.

The ENZARAD trial is for men with localised prostate cancer at high risk for recurrence deemed suitable for external beam radiation therapy.

This study is for men with advanced prostate cancer (proven metastatic disease or castrate resistant biochemical progression).

This trial is for men with localised prostate cancer at high risk for recurrence deemed suitable for external beam radiation therapy.

This study examines the implications for sexual practices and sexual identity in gay and bisexual men and their partners with prostate cancer.

© ANZUP 2017. All rights reserved.